Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.
作者信息
Anstey A
机构信息
Department of Dermatology, University Hospital of Wales, Cardiff, UK.
出版信息
J R Soc Med. 1995 Mar;88(3):155P-160P.
Abstract
摘要
相似文献
1
Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.硫唑嘌呤在皮肤病学中的应用：基于甲基化药物遗传学理解进展的综述
J R Soc Med. 1995 Mar;88(3):155P-160P.
2
Azathioprine: a guide for the management of dermatology patients.硫唑嘌呤：皮肤科患者管理指南。
Dermatol Ther. 2007 Jul-Aug;20(4):206-15. doi: 10.1111/j.1529-8019.2007.00134.x.
3
Azathioprine.
Int J Dermatol. 1981 Sep;20(7):461-7. doi: 10.1111/j.1365-4362.1981.tb04904.x.
4
A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients.硫唑嘌呤及其他硫嘌呤类药物在皮肤病患者中安全有效应用的药物遗传学基础。
J Am Acad Dermatol. 1995 Jan;32(1):114-6. doi: 10.1016/0190-9622(95)90195-7.
5
Pharmacogenetics in dermatology: a patient-centered update.皮肤病药理学：以患者为中心的最新进展。
Int J Dermatol. 2013 Aug;52(8):1005-12. doi: 10.1111/j.1365-4632.2012.05793.x. Epub 2013 Jun 20.
6
Should we test TPMT enzyme levels before starting azathioprine?在开始使用硫唑嘌呤之前，我们应该检测硫嘌呤甲基转移酶（TPMT）的酶水平吗？
Hematology. 2007 Aug;12(4):359-60. doi: 10.1080/10245330701283959.
7
Recent advances in the pharmacogenomics of thiopurine methyltransferase.硫嘌呤甲基转移酶药物基因组学的最新进展
Pharmacogenomics J. 2001;1(4):254-61. doi: 10.1038/sj.tpj.6500066.
8
Guidelines for prescribing azathioprine in dermatology.皮肤科硫唑嘌呤处方指南。
Br J Dermatol. 2004 Dec;151(6):1123-32. doi: 10.1111/j.1365-2133.2004.06323.x.
9
Bioequivalence of azathioprine products.
Rev Gastroenterol Disord. 2003 Fall;3(4):219-23.
10
Therapeutic lessons from pharmacogenetics.药物遗传学的治疗经验。
Ann Intern Med. 1997 Apr 15;126(8):653-5. doi: 10.7326/0003-4819-126-8-199704150-00012.
引用本文的文献
1
Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase.硫唑嘌呤诱发的脓疱病患者全血细胞减少及红细胞硫嘌呤甲基转移酶缺乏
BMJ. 2005 Feb 12;330(7487):350-1. doi: 10.1136/bmj.330.7487.350.
本文引用的文献
1
Immunosuppressive agents in dermatology.皮肤科中的免疫抑制剂。
Dermatol Clin. 1993 Jan;11(1):73-85.
2
3
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.除泼尼松龙外，硫唑嘌呤和血浆置换治疗大疱性类天疱疮的对照试验。
Arch Dermatol. 1993 Sep;129(9):1203-4.
4
Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.人硫嘌呤甲基转移酶：T84结肠癌细胞cDNA的分子克隆与表达
Mol Pharmacol. 1993 Jun;43(6):878-87.
5
Thiopurine methyltransferase activity in a French population: h.p.l.c. assay conditions and effects of drugs and inhibitors.法国人群中的硫嘌呤甲基转移酶活性：高效液相色谱法检测条件及药物和抑制剂的影响
Br J Clin Pharmacol. 1994 Jul;38(1):1-8. doi: 10.1111/j.1365-2125.1994.tb04314.x.
6
Pityriasis rubra pilaris.毛发红糠疹
Clin Exp Dermatol. 1980 Mar;5(1):105-12. doi: 10.1111/j.1365-2230.1980.tb01676.x.
7
Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.巯嘌呤药物遗传学：红细胞硫嘌呤甲基转移酶活性的单基因遗传
Am J Hum Genet. 1980 Sep;32(5):651-62.
8
Treatment of chronic actinic dermatitis with azathioprine.硫唑嘌呤治疗慢性光化性皮炎
Br J Dermatol. 1984 Jun;110(6):691-5. doi: 10.1111/j.1365-2133.1984.tb04706.x.
9
Adjuvant therapy of pemphigus.天疱疮的辅助治疗
Arch Dermatol. 1984 Jul;120(7):941-51.
10
Immunosuppressive therapy in ocular cicatricial pemphigoid.眼部瘢痕性类天疱疮的免疫抑制治疗
Am J Ophthalmol. 1983 Oct;96(4):453-9. doi: 10.1016/s0002-9394(14)77908-5.
Zotero 插件